Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (NASDAQ:SNGX)

1.92
Delayed Data
As of 4:00pm ET
 +0.01 / +0.52%
Today’s Change
1.74
Today|||52-Week Range
5.08
-14.67%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close1.91
Today’s open1.90
Day’s range1.90 - 1.97
Volume26,381
Average volume (3 months)79,996
Market cap$16.7M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+55.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+19.16%
P/E ratioNM
Price/Sales0.77
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...-0.06-5.73%
NDRAENDRA Life Sciences ...+0.19+4.68%
CLSNCelsion Corp-0.02-0.71%
RXIIRxi Pharmaceuticals ...-0.00-0.39%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 22, 2018
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$10.4M
Annual profit (last year)-$3.2M
Net profit margin-31.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer, Secretary &
Senior VP
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts